GlassScriptPhysician profile
Ashley Hilburn
NPI 1265996995
$1,991.05
in general payments reported to CMS, 2019-2025
32 companies · $540 in 2025
The $540 reported for 2025 was more than what 76% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $190 · 2022: $270 · 2023: $482 · 2024: $510 · 2025: $540.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,531.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,531.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $363.25 | 2022-2025 | Ozempic, Wegovy, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $282.65 | 2022-2025 | Airsupra, Farxiga, Breztri |
| Abbvie INC. | $197.39 | 2022-2025 | |
| Shield Therapeutics INC | $161.03 | 2023-2025 | Accrufer |
| Abbott Laboratories | $106.48 | 2021-2025 | Freestyle Libre 3 |
| Amgen INC. | $93.06 | 2021-2024 | Krystexxa, Repatha, Otezla |
| Pfizer INC. | $88.53 | 2022-2025 | |
| Lilly USA, LLC | $57.70 | 2023-2025 | Mounjaro, Zepbound, Trulicity |
| Esperion Therapeutics, INC. | $54.82 | 2021 | |
| Phathom Pharmaceuticals, INC. | $54.46 | 2023-2024 | Voquezna |
| Exact Sciences Corporation | $52.19 | 2023-2025 | Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $50.48 | 2022 | |
| Amarin Pharma, INC. | $46.55 | 2021 | |
| Dexcom, INC. | $38.76 | 2022-2025 | Dexcom G6 Transmitter |
| Glaxosmithkline, LLC. | $35.75 | 2023 | Shingrix, Arexvy, Bexsero |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $33.46 | 2025 | |
| Edwards Lifesciences Corporation | $29.34 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Ultragenyx Pharmaceutical INC. | $26.31 | 2023 | |
| Boston Scientific Corporation | $21.04 | 2023 | Watchman Access System |
| Sanofi-Aventis U.S. LLC | $20.90 | 2022 | |
| Novartis Pharmaceuticals Corporation | $20.45 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.64 | 2024 | Trulance, Xifaxan |
| Idorsia Pharmaceuticals US INC | $15.82 | 2022 | |
| Axsome Therapeutics, INC. | $15.73 | 2025 | Auvelity |
| Dynavax Technologies Corporation | $14.70 | 2023 | Heplisav-B |
| Bayer Healthcare Pharmaceuticals INC. | $14.50 | 2022 | |
| Astellas Pharma US INC | $14.25 | 2021 | |
| Daiichi Sankyo INC. | $13.91 | 2022 | |
| Xeris Pharmaceuticals, INC. | $13.07 | 2024 | Gvoke Hypopen |
| Biohaven Pharmaceutical Holding Company LTD. | $12.55 | 2022 | |
| Hikma Pharmaceuticals USA | $11.14 | 2021 | |
| Eyevance Pharmaceuticals LLC | $11.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Hilburn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.